title: Hazards of early BCG vaccination: BCGitis in a patient with chronic granulomatous disease.
authors.affiliation: Department of Pediatrics, Tokyo Medical University, Tokyo, Japan. hisashi@tokyo-med.ac.jp
authors.forename: Hisashi
authors.initials: H
authors.lastname: Kawashima
authors.forename: Daisuke
authors.initials: D
authors.lastname: Hasegawa
authors.forename: Mikage
authors.initials: M
authors.lastname: Nakamura
authors.forename: Shinji
authors.initials: S
authors.lastname: Mochizuki
authors.forename: Yasuyo
authors.initials: Y
authors.lastname: Kashiwagi
authors.forename: Shigeo
authors.initials: S
authors.lastname: Nishimata
authors.forename: Satoshi
authors.initials: S
authors.lastname: Sato
authors.forename: Masato
authors.initials: M
authors.lastname: Sasamoto
authors.forename: Kouji
authors.initials: K
authors.lastname: Takekuma
authors.forename: Akinori
authors.initials: A
authors.lastname: Hoshika
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Nunoi
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006105:Granulomatous Disease, Chronic / Q000150:complications* / Q000175:diagnosis; D006801:Humans; D007223:Infant; D008297:Male; D014057:Tomography, X-Ray Computed; D014376:Tuberculosis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D014611:Vaccination / Q000009:adverse effects*
chemical_list: D000276:Adjuvants, Immunologic; D000995:Antitubercular Agents; D001500:BCG Vaccine